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In 1997, 8 million new cases of tuberculosis (TB) were
reported worldwide; 3.5 million cases were considered highly
contagious (1). With Africa and some countries having up to
20% of their populations infected with HIV, AIDS will have a
major impact on TB in coming years (2). Emergence of
multidrug-resistant (MDR) strains of Mycobacterium tuber-
culosis is also of great epidemiologic concern (3). In this
context, molecular fingerprinting of M. tuberculosis complex
isolates is a powerful tool that permits detection of
transcontinental spread of TB (4) and outbreaks (5). Our
laboratory has described a preliminary spoligotyping
database that suggested the biogeographic specificity of some
of the spoligotypes from the Caribbean (6). The initial aim of
this work was twofold. First, such an inventory was
mandatory to detect and estimate the relative importance of
TB of foreign origin in the French Caribbean. Although the
incidence of TB in Martinique and Guadeloupe is comparable
with that in metropolitan France (approximately 10/100,000
new cases each year), this region is part of an area of Latin
America and the Caribbean with high TB prevalence. Second,
we used spoligotyping results to infer potential phylogenetic
relationships of M. tuberculosis strains in the Caribbean
region and the history of TB by using molecular markers. An
updated database could also be helpful in developing new
statistical approaches in the field of population genetics of
circulating M. tuberculosis clinical isolates.
By systematically analyzing published spoligotypes, we
have now collected 3,319 spoligotyping patterns of various
origins in a single database, essentially from Europe and the
USA (Table 1). This database includes 259 shared types
containing 2 to 476 patterns (because of the size of this
database, a graphic of it appears online only, at http://
www.cdc.gov/ncidod/EID/vol7no3/sola_data.htm). The main
database also includes 540 “orphan patterns” (clinical
isolates showing a unique spoligotype), for a current total of
799 distinct spoligotype patterns. This article describes the
nomenclature and phylogenetic reconstruction of these 259
shared types.
The Database
Spoligotyping based on the variability of the Direct
Repeat (DR) locus and analysis of a variable number of
tandem DNA repeats (VNTR) of M. tuberculosis were
performed according to the original protocols (7,8). For the
construction of the database, spoligotyping results were
entered into Excel spreadsheet files in chronological order,
according to the availability of results from published articles
and our own investigations. The database was searched
regularly for new shared types, i.e., identical spoligotypes
shared by two or more patient isolates. For phylogenetic
reconstruction, the spoligotyping results were entered into
Recognizer software of the Taxotron package (Taxolab,
Institut Pasteur, Paris), as recommended (9). The “1-Jaccard”
Index was calculated for each pairwise comparison of patterns
(10), and the neighbor-joining algorithm was used for
building trees (11).
The source of the data and its representativeness are
shown in Table 1. Of 3,319 individual spoligotypes in our
database, most (2,418 [73%]) were either from Europe (1,142
[34%]) or the USA (1,283 [39%]). Spoligotypes shared between
the USA and Europe totaled 1,286 isolates distributed among
45 shared types (Europe, n=461; USA, n=825). A statistical
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We give an update on the worldwide spoligotype database, which now contains
3,319 spoligotype patterns of Mycobacterium tuberculosis in 47 countries, with
259 shared types, i.e., identical spoligotypes shared by two or more patient
isolates. The 259 shared types contained a total of 2,779 (84%) of all the
isolates. Seven major genetic groups represented 37% of all clustered isolates.
Two types (119 and 137) were found almost exclusively in the USA and
accounted for 9% of clustered isolates. The remaining 1,517 isolates were
scattered into 252 different spoligotypes. This database constitutes a tool for
pattern comparison of M. tuberculosis clinical isolates for global epidemiologic
studies and phylogenetic purposes.Synopses
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analysis was performed for the 1,286 isolates to evaluate the
biogeographic specificity of the shared types and assess
potential sampling bias by using a sample homogeneity test
derived from the chi-square test (see below).
Results and Discussion
Description of Database
The 3,319 spoligotypes were grouped into 259 shared
types containing 2,779 (84%) of the isolates and 540 (16%)
orphan spoligotyping patterns (clinical isolates showing
a unique spoligotype; results not shown; see online
graphic of database, http://www.cdc.gov/ncidod/EID/vol7no3/
sola_data.htm). This gives a current total of 799 distinct
spoligotype patterns in our database.
The distribution of shared types, their respective sizes,
and their relative distribution in different locations (distinct
countries or geographic regions) are summarized in Figure 1.
The 24 most frequent shared types totaled 1,804 (65%)
isolates (Figure 1A); 7 types were highly frequent,
representing 1,250 (45%) isolates. The Beijing type (type 1)
was most frequent and represented 18% of isolates. Two types
(119 and 137), which were almost exclusively found in the
USA, accounted for 9% of isolates and may be specific for
American populations or outbreaks (12). Types 53 and 50
accounted for 8% and 6% of isolates and were found in 17 and
15 locations, respectively. Two other types (types 42 and 47)
Table 1. Source of data for 3,319 spoligotypes of Mycobacterium
tuberculosis used to generate the database of 259 shared types
No. of
isolates        Origina       Year           Reference
136     Denmark       1999                  31
147         Italy       1999                  32
157         Cuba       1998                  33
1b    Philippines       1997                  34
3          Peru       1998                  35
18          USA Unpublished      R. Frothingham
105         France       1997                  36
167  United Kingdom       1997                  37
296         France Unpublished          This study
28      Zimbabwe       1998                  38
32   Guinea-Bissau       1999                  25
118  The Netherlands       1997                    7
68 Various countries       1999                  15
58         France Unpublished        J. Maïsetti &
        B. Carbonnelle
62         Russia Unpublished       O. Narvskaya
84     West Africa       1999                  39
5       Thailand Unpublished P. Palittapongarnpim
14       Romania       1997                  40
17          Brazil       1999                  41
5b          Spain Unpublished        S. Semper &
         C. Martin
1,283           USA       2000                  12
1b  United Kingdom       1999                  42
19 The Netherlands       1998                  43
1b The Netherlands       1999                  19
69    Far East Asia       1995                  44
69       Caribbean       1999                    6
356       Caribbean Unpublished          This study
aAlthough a potential sampling bias cannot be excluded, the sampling of isolates and their
representativeness (in order of description) was as follows: Denmark, of 249 isolates
described with a low copy number of IS6110 collected since 1992 (exhaustivity 93%), 24
shared types, representing 136 spoligotypes, were retained (9 other shared types,
representing 49 isolates that were found exclusively in Denmark
(S1,S2,S4,S19,S22,S23,S27,S30,S33), were not included in the present analysis; Italy, of
158 isolates from 156 patients in Verona collected during 1996-1997, 147 spoligotypes were
retained; Cuba, of 160 isolates typed (obtained from a pool of 578 smear-positive sputa
collected during 1994-1995), 157 spoligotypes described (exhaustivity 36%) were retained;
Philippines, no data except for a single spoligotype available; Peru, of 29 strains isolated
during 1995-1996 from the sputa of patients in Lima and Cuzco, only 3 were retained in this
study since the remaining isolates shared spoligotypes with patients in Texas (12) and are
included in the 1,283 Texan profiles; USA, 18 clinical isolates from the collection of R.
Frothingham (representativeness unknown); France, 111 isolates from 105 hospitalized
patients in Paris obtained during 1993 (patients were from three major hospitals that
represented 5% of the total public hospital beds in Paris); United Kingdom, 167 isolates
from all the culture-positive tuberculosis (TB) patients from three large hospitals in
northwest London (without any indication of period of recruitment); France, 296 isolates
sent for reference purposes during a 3-year period to the Centre National de Référence des
Mycobactéries, Institut Pasteur, Paris; Zimbabwe, 28 spoligotypes obtained directly from
sputum samples during a 1-month recruitment period (December 1995) of sputum-positive
TB cases representing 20% of all cases; Guinea-Bissau, of 229 spoligotypes obtained from
samples of 900 patients with suspected TB cases during 1989-1994, only 32 spoligotypes
were fully described by the authors, and were retained for the analysis; the Netherlands,
118 isolates of unspecified representativeness from the collection of National Institute of
Health (RIVM, Bilthoven); international multicenter study, 68 of 90 isolates from 38
countries representing the five continents; France, 58 isolates during a 1-year (1999)
recruitment in the University Hospital of Angers; Russia, 62 isolates representing the St.
Petersburg area collected during 1997-1999; West Africa, 84 isolates from Ivory Coast and
around Dakar, Senegal, collected during 1994-1995; Thailand, 5 isolates from northern
Thailand (unknown representativeness); Romania, 14 isolates of unknown representative-
ness; Brazil, 17 spoligotypes out of 91 isolates from a São Paulo hospital in 1995 (unknown
representativeness); Spain, 5 multidrug-resistant isolates (unknown representativeness);
USA, 1,429 clinical isolates from 1,283 patients during 1994-1999 that are part of an
ongoing population-based study in Houston, Texas; United Kingdom, a single spoligotype
from ancient DNA extracted from a bone sample; the Netherlands, 19 spoligotypes obtained
from paraffin-wax embedded tissue samples previously collected during 1983-1993
(unknown representativeness); the Netherlands, a single spoligotype from a previous study
(unknown representativeness); Far East Asia, 69 isolates from China and Mongolia
obtained during 1992-1994 (unknown representativeness); Caribbean, 425 clinical isolates
from a population-based ongoing study that includes all cultures isolated in Guadeloupe,
Martinique, and French Guiana since 1994 and covers a 1 million population (exhaustivity
100%). Some isolates in this pool came from patients from other countries (essentially
neighboring countries such as Haiti, Dominican Republic, Brazil, Commonwealth of
Dominica, Barbados, and Surinam).
bDescription of a given spoligotype without precise number of isolates within  this type.
Figure 1. Histograms derived from database (graphic online at
http://www.cdc.gov/ncidod/EID/vol7no3/sola_data.htm) summariz-
ing the distribution of shared types (A), their respective sizes (B), and
their relative distribution in different locations (C).Synopses
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accounted for 4% of the isolates and were found in 11
countries. The remaining isolates (n=1,517) were scattered
into 235 types. Figure 1B shows the relative sizes of 259
shared types; 109 shared types (42%) contained only two
patients each and 38 shared types contained only three
patients each. Inversely, 24 shared types containing >20
patients totaled 1,804 (65%) isolates. Finally, the distribution
“unique” versus “ubiquitous” shared types (reported in one
location versus found in two or more locations) is shown in
Figure 1C; 122 (47%) shared types were reported from a single
location, 69 (26%) were from two locations, and 25 (10%) were
from three locations. Inversely, the most ubiquitous types, in
increasing order of distribution, were 33 and 37, 20, 52, 42, 50,
and 53. Thus, most M. tuberculosis shared types contained a
low number of patient isolates and were confined
geographically, whereas a minority contained a high number
of patient isolates and were highly disseminated. The finding
of identical spoligotypes in distant countries may be
explained either by recent or past transmission events or by
phylogenetic convergence. However, the evolution of the DR
locus relies on at least three independent mechanisms,
namely, homologous recombination (13), replication slippage
(14, 15), and insertion sequence-mediated transposition (16-
19), which does not favor a fortuitous convergence.
Geographic Distribution of Shared Types in the Database
Analysis of geographic distribution of the shared types
(see online graphic of database, http://www.cdc.gov/ncidod/
EID/vol7no3/sola_data.htm) permitted us to split our
collection into two broad categories: those reported in a single
area (n=122, Table 2) and those reported in two or more areas
(n=137). In the latter category, matching analysis for 69
spoligotypes found in four broad geographic areas, namely,
Africa, the Americas (North, Central and Caribbean, and
South America), Europe, and Asia (Middle East, and Far East
Asia), is shown in Table 3. Contrary to ubiquitous
spoligotypes such as type 1, 53, and 50, which have been found
in all regions, this is an attempt to define potential inter-
regional and inter-continental flow of M. tuberculosis isolates
so far confined to limited geographic areas. The most frequent
matches were found for clusters in European countries
(n=17), followed by Europe and North America (n=8), Europe
and Central America and the Caribbean (n=5), and Europe
and South America (n=4) (Table 3). These matches may
underline both recent transcontinental transmission events
and the history of TB spread in the New World through
European settlers.
A total of 25 shared types were reported in three
countries. Among these, 8 types were exclusively found either
in Europe (types 10,22,161) or the Americas (types
5,67,70,93,130); 10 types were shared between two European
countries and a country of another region (types
35,49,59,86,115,118,136,138,139,150); 5 types were shared
between two countries of the Americas with a country in
Europe (types 92,119,168,185,190); 1 type was shared
between a European country and two African countries (type
125); and 1 type was shared between Asia, Europe, and the
USA (type 124). Finally, 15 types were found in four countries;
1 type (type 41) was exclusively found in Europe and may be
specific for this continent. Fourteen other types were
distributed as follows: Europe + Americas, 8 types (types
3,7,19,31,40,51,137,152); Europe + Africa, 1 type (type 21);
Europe + Asia + Americas, 3 types (type 8,89,167); Europe +
Americas + Africa, 1 type (type 64); and Europe + Africa +
Asia, 1 type (type 126). Finally, 28 types were reported in five
or more countries, suggesting that these types are widespread
and may constitute the ubiquitous types such as the Beijing
type (type 1 in our database) or the Haarlem type (type 47).
The only exception in this category was type 17, which was
found in six countries in the Americas and may be specific for
this region. Future population studies should focus on these
ubiquitous types to better define their relative prevalence in
each country.
Table 2. Geographic distribution of potentially specific shared types of
Mycobacterium tuberculosis reported in a single location (n=122)
No. of
Region      Country  types                Types
Americas    Guadeloupe   7 12,13,14,15,30,103,259
French Guiana   4 66,76,94,96
       Cuba   4 71,74,80,81
        USA 46 192,194,197-199,201,202,
 205,206,208,210-217,219-
 235,237-239,241,243,246,
 248,256-258
Europe The Netherlands   4 9,18,28,90
United Kingdom   6 16,23,27,38,43,100
       France 27 55,57,107-114,116,120,122,
 140,141,143-148,170,171,
 173,174,184,186
        Italy   9 155,157-160,163,165,
 166,169
       Spain   2 104,106
      Russia   3 251,252,253
Africa     Zimbabwe   6 79,82-85,87
Guinea-Bissau   1 188
Asia    Philippines   1 69
     Mongolia   2 97, 98
Table 3. Total number of matches found in matching analysis of the
shared types (n=69) found at two geographic locations*
Americas
 Central       Asia*
  North America/   South Middle Far
Matches* Africa America Caribbean AmericaEurope East East
Africa 3a 3b 2c 1d 5e 00
North NA+ 6f 4g 8h 01
  America
Central 2i 4j 5k 00
  America
South 3l 4m 00
  America
Europe 17n 10
Asia 0 0
  (Middle
  East)
Asia (Far 0
  East)
*Indices a to n refer to the designation of the matching types. For full
description of the  matching shared type, see database (online graphic at http:/
/www.cdc.gov/ncidod/EID/vol7no3/sola_data.htm). Spoligotyping data for
isolates from Asia are scarce; hence, only two matches involving the Middle
East and Far East were found (shared types 127 and 249, respectively). †NA,
not applicable (matches were searched only for shared types existing between
two countries or regions; as no data were available for Canada, comparison of
isolates within North America was not feasible).Synopses
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Biogeographic Analysis of European
Versus American Spoligotypes
Several possible scenarios could account for the
introduction and spread of TB in the Americas; however,
documented contact with Europeans is considered too recent
to account for the widespread distribution of the disease by
AD 1000 (20). One hypothesis suggests that TB may have
penetrated the Americas through human migration from Asia
via the Bering Strait (21). Another scenario suggests TB’s
initial introduction as a zoonosis that became an
anthropozoonosis after cattle were domesticated (20,21). In
this context, of the 259 shared types in our database, 59 were
exclusively reported in the Americas, whereas 50 were found
only in Europe (Table 2). This biogeographic dichotomy may
signal the specific history of the disease in each continent. As
enough data were present for the USA and Europe (2,418
[73%] isolates), a statistical analysis of distribution of shared
types found in those two areas was performed.1 Of 45 shared
types in this category, results showed that differences in the
distribution of certain shared types (1,19,20,25,26,37,44,48,
50,52,53,118,137) between the USA and Europe were highly
significant, and sampling bias could not explain the
differences observed (Table 4). On the other hand, the
differences observed in the distribution of shared types 2,8,
33,34,47,58,62,92,138, and 139 between the USA and Europe
were not statistically significant, and in this case sampling
bias could not be fully excluded for the differences observed.
Finally, our database described 58 isolates of the shared type
42 that were present in 11 countries (a ubiquitous type), but
not a single isolate of type 42 was present among the 1,283
isolates from Texas (12).
Use of Database for Epidemiologic Studies
Essentially working in a Caribbean setting for last 6
years with systematic typing of all M. tuberculosis isolates
from Guadeloupe, Martinique, and French Guiana, we
initially focused on spoligotypes that may be specific to our
region. Of 259 shared types, 85 types were present in the
Caribbean. Of these, 69 were common to the Caribbean and
the rest of the world, and 16 were reported only from the
Caribbean (types 5,12,13,14,15,30,63,66,68,72,76,77,94,
96,103,259). Although TB has a penchant to be latent for
years or decades, because of an exhaustive (nearly 100%)
recruitment of isolates from the French Caribbean for last 6
years, finding a previously unreported spoligotype in our
region may constitute indirect evidence for a newly imported
case of TB in most instances, particularly if an epidemiologic
investigation does not suggest reactivation of old disease.
As far as global epidemiologic studies are concerned, this
database also emphasizes the existence of highly prevalent
families of M. tuberculosis isolates, e.g., the Beijing type,
which represents a diverse collection of clones including the
notorious multidrug-resistant strain W and other W-like
drug-sensitive isolates (5,22). Studies focusing on
M. tuberculosis isolates from developing countries, where TB
is highly prevalent, would improve understanding of the
worldwide circulation of tubercle bacilli and provide insights
into their epidemiology, phylogeny, and virulence.
Phylogenetic Reconstruction of M. tuberculosis
For phylogenetic analysis (23), a neighbor-joining tree
was constructed by calculating the 1-Jaccard Index (10,24).
This tree (Figure 2) incorporates the data for 252
M. tuberculosis shared types instead of the 259 allele types
Table 4. Analysis of distribution of shared types found in both USA
and Europea
Europe USA World
No. %b No.   % No.   %
Type (k1) (p1) (k2) (p2) (p0) d/σ d quotient
c
1 21 1.8 326 25.5 476 14.4 15.3d
2   6 0.5     2   0.2   28   0.8   1.6
8 10 0.9     7   0.5   19   0.6   0.9
19   1 0.1   23   1.8   27   0.8   4.2d
20   8 0.7     2   0.2   20   0.6   2.1d
25 13 1.1     3   0.2   17   0.5   2.7d
26 22 1.9     5   0.4   28   0.8   3.6d
33 13 1.1   10   0.8   38   1.2   0.9
34   6 0.5     9   0.7   21   0.6   0.6
37 17 1.5     2   0.2   28   0.8   3.7d
44 12 1.1     1   0.1   15   0.5   3.3d
47 25 2.2   23   1.8   65   2.0   0.7
48 34 3.0     7   0.5   41   1.2   4.6d
50 56 4.9   32   2.5 155   4.7   3.1d
52 29 2.5     7   0.5   40   1.2   4.0d
53 79 6.9   46   3.6 218   6.6   3.6d
58   4 0.4     7   0.5   17   0.5   0.7
62   7 0.6     4   0.3   15   0.5   1.1
92   2 0.2     8  0.6   14   0.4   1.7
118   8 0.7     1   0.1     9   0.3   2.5d
119   2 0.2 110   8.6 115   3.5   9.6d
137 10 0.9 134 10.5 146   4.4   9.7d
138   5 1     1   0.1     6   0.2   1.8
139 19 1.7   19   1.5   38   1.2   0.3
aResults are given for 24 of 45 shared types that contained enough isolates to
compare the results statistically.
bPercentages were calculated on the basis of 1,142 (n1), 1,276 (n2), and 3,319
individual spoligotypes reported, respectively, for Europe (p1), USA (p2), and
the full database available for the world.
cThe quotient d/σ d was calculated using the equation d/σ d=p1-p2/√ p0q0(1/n1+1/n2),
where d is the absolute value of the difference between p1 and p2, σ d  is the
standard deviation of the repartition law of d which follows a normal
distribution and can be calculated by the equation σ d =√ p0q0 (1/n1+1/n2), and
where p0 is best estimated by the equation p0=k1+k2/n1+n2=n1p1+n2p2/n1+n2. In
this equation, individual sampling sizes are n1 and n2, the number of
individuals within a given shared-type “x” are k1 and k2, and the
representativeness for the two samples is p1=k1/n1 and p2=k2/n2.
dIf the absolute value of the quotient d/σ d<2, the variations observed in the
distribution of isolates for a given shared type were not statistically significant
and could be due to a sampling bias. Inversely, if d/σ d>2, then the differences
observed in the distribution of isolates for a given shared type were statistically
significant and not due to a potential sample bias.
1For this purpose, the independent sampling sizes for Europe and the USA were taken as n1 and n2, the number of individuals within a given shared-type “x” was
k1 and k2, and in this case, the representativeness of the two samples was p1=k1/n1 and p2=k2/n2, respectively. To assess if the divergence observed between p1 and
p2 was due to sampling bias or the existence of two distinct populations, the percentage of individuals (p0) harboring shared-type “x” in the population studied was
estimated by the equation p0= k1+k2/n1+n2=n1p1+n2p2/n1+n2. The distribution of the percentage of shared-type “x” in the sample sizes n1 and n2 follows a normal
distribution with a mean p0 and a standard deviation of  √ p0q0/n1 and √ p0q0/n2, respectively, and the difference d=p1-p2 follows a normal distribution of mean p0-p0=0
and of variance  σ d
2= σ p1
2+σ  p2
2 = p0q0/n1+p0q0/n2 or σ d
2=p0q0 (1/n1+1/n2). The two samples being independent, the two variances were additive; the standard deviation
σ d=√ p0q0 (1/n1+1/n2) was calculated, and the homogeneity of the samples tested was assessed using the quotient d/σ d=p1-p2/√ p0q0(1/n1=1/n2) . If the absolute value
of the quotient d/σ d<2, the two samples were considered to belong to the same population (CI 95%) and the variation observed in the distribution of isolates for given
shared types could be due to a sampling bias. Inversely, if d/σ d>2, then the differences observed in the distribution of isolates for given shared types were statistically
significant and not due to potential sample bias.Synopses
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described in the online database (types 253 to 259 were added
recently after the completion of phylogenetic analysis). At an
arbitrary distance of 0.2, one may easily distinguish nearly 15
branches that may contain significant phylogenetic informa-
tion, as seen below for four selected branches (A to D) by
combining results using independent genetic markers (Figure
3). As shown in Figure 2 and 3A, the homogeneous branch A
(mainly present in Europe, West Africa, and South America)
contains 20 types characterized by the absence of spacers 29
to 32 and 34. Such a family of isolates was recently described
in Guinea-Bissau and also found to harbor a low copy number
of IS6110 (25). Information concerning katG283-gyrA95 allele
combination was available for 5 of these 20 types and showed
that branch A belonged to the major genotypic group 1 as
defined previously (26) and may represent an ancestral clone
of M. tuberculosis isolates originating in Africa, Asia, or both
(27; this work). For this branch, VNTR information was
available for 3 of 20 types and showed a high exact tandem
repeat (ETR)-A copy number (between 4 to 7; Figure 3A),
which is common both for M. bovis and M. africanum (8,28).
Branch B shared a common root with branch A (Figure 2)
but was clearly distinct from the population in branch A, an
observation corroborated both by VNTR and katG283-gyrA95
types (Figure 3B). All the isolates in branches A and B were of
the major genetic group 1, as defined (26), except for a single
isolate of the major genetic group 2 in branch B (type 199); the
significance of this observation is not clear. Branch C was
composed of two subbranches, which are likely to be of
different phylogenetic significance (Figure 3C); the upper
part related to the Haarlem family, as previously defined (15),
and was highly homogeneous upon VNTR typing (alleles
32333), whereas the lower part was quite heterogenous
(alleles 42431, 31333, 44553).
Finally, branch D comprised a subfamily of the
spoligotypes that all missed spacers 33-36 (Figure 3D). This
branch, which contained 30 different shared types, was easily
Figure 2. Phylogenetic tree of shared types of Mycobacterium
tuberculosis constructed by pairwise comparison of patterns using the
“1-Jaccard” index and the neighbor-joining algorithm. Approximately
15 branches may be visualized at an arbitrary distance of 0.2. The
position of some reference strains (M. tuberculosis H37Rv, M. bovis
BCG) or well-studied spoligotyping families of isolates (Beijing,
Haarlem, and the M. africanum group) are also indicated.
Figure 3. Enlargement of
branches A to D from the
Mycobacterium tuberculosis phy-
logenetic tree (Figure 2). Num-
bers in standard characters
refer to spoligotype numbers
according to our database; those
in boxes describe both the
spoligotype number and variable
number of tandem DNA repeats
(VNTR) allele designations. Itali-
cized numbers refer to
spoligotype followed by the
Houston spoligotype designation
(12), and the major genetic
groups 1 to 3 defined on the basis
of katG283-gyrA95 allele combi-
nation  (24). A and B show
distinct branches belonging es-
sentially to the major genetic
group 1 with a high exact
tandem repeat (ETR)-A copy
number; C and D show branches
that include some strains of the
“Haarlem family” belonging to
the major genetic group 2 with a
low ETR-A copy number.Synopses
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characterized by simultaneous absence of spacers 21-24 and
33-36, and constitutes a highly ramified but homogeneous
family on the basis of its belonging to the major genetic group
2 of Sreevatsan et al. (26), and the presence of two copies of the
ETR-A allele upon VNTR typing. Frequently found in
southern Europe and Central and South America, the
ancestral type of this family (type 42) may have evolved by
stepwise mutation to give, successively, types 20 and 17
(Figure 3D). This assumption is corroborated by the position
of the respective types in the tree and their spoligotyping and
VNTR patterns; type 42 (all spacers present except 21 to 24
and 33 to 36, VNTR 22433), type 20 (identical to type 42 plus
a single missing spacer 3, VNTR identical to type 42), and
type 17 (identical to type 20 plus a single missing spacer 13,
VNTR 22321).
These results show that branches A and B are likely to be
of an older evolutionary origin than branches C and D.
Källenius et al. (25) hypothesized that branches A and B could
find their evolutionary origin in West Africa, whereas
branches C and D could be of European descent. However,
since the global evolutionary rate of the DR locus may involve
many independent mechanisms, this tree is likely to
incorporate systematic yet unknown errors (6); therefore, a
detailed analysis of the robustness of each potential
phylogenetic link is under investigation.
Conclusion
We have presented an update of a database of
M. tuberculosis spoligotypes with a detailed description of 259
shared types. This database may help to address major
aspects linked to recent mycobacterial reemergence,
evolutionary history, and future epidemiologic studies. Our
results demonstrate that a few major families of conserved
spoligotypes are well distributed throughout the world,
whereas others are specific for certain geographic regions.
Thus, the current epidemiologic picture of TB appears to be
based both on the persistence of ancestral clones of
M. tuberculosis as well as those emerging more recently, e.g.,
the Beijing type (type 1 in our database), which also includes
the MDR strain W from New York City. A future correlation
between genotyping and resistance data and the respective
prevalence of various clones region by region may provide
more insight into the global circulation of TB and help
establish priorities in TB control programs. For example,
because we have typed all M. tuberculosis clinical isolates in
our insular setting for last 6 years, introduction of a
previously unreported clone in Guadeloupe may be detected
and, when placed in epidemiologic context, may either be
classified as a newly imported case of TB or as a reactivation.
Simultaneously, an epidemiologic investigation around the
case is immediately initiated by local health authorities. A
comparison of the newly imported clone with those in the
database sometimes suggests a probable link to a specific
community or, alternatively, regional, national, or interconti-
nental importation of the disease.
Concerning the global phylogeny of M. tuberculosis, the
pairwise comparison of the 252 shared types by calculation of
the 1-Jaccard index and the neighbor-joining algorithm
underscored phylogenetic relationships between some of the
families of spoligotypes described. Four major families of
spoligotypes (branches A-D) were discussed in detail, and the
results were corroborated by VNTR and katG—gyrA
polymorphism data, which support the robustness of the
branchings proposed. Nevertheless, a detailed and more
exhaustive analysis of evolutionary and historical spreading
of the different families of tubercle bacilli is a long-term goal
requiring a never-ending compilation of data. Ideally, this
database could be expanded to incorporate detailed M. bovis
and M. africanum results so as to infer the global phylogeny of
all members of the M. tuberculosis complex.
It has been suggested that the evolutionary rate of
M. tuberculosis may be strain dependent (29). In this context,
our investigation also pointed out a previously unnoticed link
between spoligotypes and the katG—gyrA polymorphism
(Figure 3), i.e., the isolates in the spoligotyping-defined
branch A belonged to the major genetic group 1 of Sreevatsan
et al. (26), whereas those in branch D belonged to the major
genetic group 2. Since the isolates in these branches came
from diverse geographic areas, we suggest that the pace of the
molecular clock of the DR locus might be much slower than
that of other markers, such as IS6110. This assumption is
supported by a recent study on the evolutionary origin of the
DR locus of M. tuberculosis (19). Finally, by comparing
observations with outcomes of a stepwise mutation model, the
insertion sequences of the tubercle bacilli are far from
equilibrium; indeed, transposition parameters appear to have
a much stronger effect on IS6110 copy number distribution
than epidemic parameters and have a direct action on
bacterial diversity of the M. tuberculosis complex (30). New
studies are needed to clarify the complex relationships
between epidemic parameters, selection factors, and genomic
evolutionary mechanisms of the tubercle bacilli.
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